Close

당신은 지금 메드트로닉코리아 사이트를 떠나고 있습니다.

당신은 방금 다른 웹사이트로 이동하기 위한 링크를 클릭하였습니다. 계속 진행하시면 메드트로닉코리아 사이트를 떠나 다른 사이트로 이동하게 됩니다.

메드트로닉은 다른 웹사이트의 내용을 검토하거나 통제하지 않으며, 당사는 다른 사이트에서 이루어지는 귀하의 사업 거래 및 계약, 귀하가 얻게 되는 정보에 대해 책임지지 않습니다. 다른 사이트로 이동하시면, 귀하가 이동하시는 해당 사이트의 이용 약관 및 개인 정보 취급 방침에 적용을 받게 됩니다. 이동하시는 다른 사이트에는 한국에서 허가 받지 않은 일부 제품이 포함되어 있을 수 있습니다.

취소 계속(opens new window)

브라우저가 오래되었습니다.

업데이트된 브라우저를 사용하면 더욱 향상된 Medtronic 웹 사이트를 경험할 수 있습니다. 지금 브라우저를 업데이트하십시오.

×

Skip to main content
Medtronic Logo
메뉴 닫기
검색 닫기
Clear
SearchLoading
  • 한국어
  • 대한민국 (South Korea)
  • Adriatic Arabia Argentina Australia and New Zealand Bangladesh Belgique (Belgium) België (Belgium) Brasil (Brazil) Bulgaria Canada Canada Europe Central/Eastern, Middle East & Africa Česká republika (Czech Republic) Chile 中国 (China) Colombia Costa Rica Србија (Serbia) Danmark (Denmark) Deutschland (Germany) Ecuador España (Spain) Europe France Ελλάδα (Greece) 香港特區 (Hong Kong SAR) Indian Subcontinent Ireland Israel  ישראל Italia (Italy) 日本 (Japan) Latinoamérica Magyarország (Hungary) México (Mexico) Nederland (Netherlands) Norge (Norway) Österreich (Austria) Panama Paraguay Perú (Peru) Philippines Polska (Poland) Российская Федерация (Russia) Portugal Puerto Rico Romania العربية الشرق Middle East Schweiz (Switzerland) Singapore Slovenská republika (Slovak Republic) South Africa and Sub-Sahara 대한민국 (South Korea) Suisse (Switzerland) Suomi (Finland) Sverige (Sweden) 台灣地區 (Taiwan) ประเทศไทย (Thailand) Türkiye (Turkey) United Kingdom United States Uruguay Україна (Ukraine) Tiếng Việt (Vietnam)
  • 환자와 질환
    • 뒤로
    • 질환 정보
    • 치료 및 요법
  • 보건의료 전문가
  • 우리 회사
    • 우리 회사로 돌아가기
    • 회사 정보
    • 사명
    • 리더십
    • 메드트로닉 사업부
    • 역사
    • 위치
    • 뉴스
    • 공지사항
    • 메드트로닉코리아
    • 채용
  • 사회적 책임
    • 사회적 책임으로 돌아가기
    • 사회적 책임
    • 임팩트 리포팅
    • 의료 형평성
    • 포용성, 다양성, 형평성
    • 지구
    • 지역사회

홈 메드트로닉 소개 역사

75th anniversary

See how our past inspires our future 

For 75 years, Medtronic has led the way with groundbreaking health tech. From humble beginnings in a garage workshop to reshaping the future, we haven’t stopped — inventing, creating, solving.
 

1949: The garage gang

Earl Bakken, a graduate student in electrical engineering, and his brother-in-law Palmer Hermundslie, an enterprising engineer, started a repair business focused on medical electronics. They named it Medtronic.  The pair were driven by passion and a deep purpose to use their scientific and entrepreneurial skills to help others. As the work increased, they added a handful of employees, who called themselves “the garage gang,” a reference to their spartan office in two boxcars used as a garage at the Hermundslie family’s Minneapolis home.
 

1957: The first battery-operated pacemaker

The power went out in Minneapolis on Halloween in 1957, endangering the lives of open-heart surgery patients who were often attached to a pacemaker. Existing pacemakers were bulky boxes wheeled around on carts and plugged into electrical outlets. Concerned for his patients, a University of Minnesota heart surgeon asked Bakken if he could create a battery-operated pacemaker. Within four weeks, Bakken did just that, and the revolutionary device began saving lives. Hermundslie, an accomplished pilot, flew all over the United States delivering pacemakers to customers. Soon, the “wearable” Medtronic pacemaker was being shipped around the world. One year later, Medtronic produced the first implantable pacemaker. 

1974-1979: Corporate citizenship

Early on, we prioritized equal employment and instituted a minority-suppliers program, two initiatives that indicated our commitment to being good citizens of the world. In 1979, the Medtronic Foundation(opens new window) was established, reinforcing a commitment to corporate citizenship, the sixth tenet of our Mission. That same year, the Bakken Society was founded to recognize technical employees who make multiple, significant contributions to Medtronic, to the biomedical industry, and to customers and patients.

1977: Prosthetic heart valve

We introduced the Medtronic-Hall mechanical heart valve in 1977. The tilting-disc valve design was a significant development and was the choice of physicians globally for nearly a quarter of a century.

1987: Expansion into neurostimulation

Building on the science of using electrical stimulation to pace the heart, Medtronic collaborated with French doctors to pioneer the world’s first deep brain stimulation system to treat movement disorders.

1993: Implantable cardioverter defibrillators

A decade of increased research and development investment paid off when we introduced our first implantable cardioverter defibrillators, designed to treat tachycardia, a dangerously fast heartbeat. 
 

2002: First remote monitoring system

Medtronic introduced the industry’s first remote monitoring system, designed to securely transfer data from patient devices to doctors via the internet. 
 

2015: Covidien acquisition

Bringing together the extensive capabilities of Covidien and Medtronic strengthened our commitment to solve some of healthcare’s greatest challenges, enabling us to help treat more people, in more places, than ever before. 

Our hybrid closed-loop system becomes the first FDA-approved device to automatically provide background insulin dosing 24-hours per day f or people living with type 1 diabetes.

2016: Breakthroughs in diabetes care

Our hybrid closed-loop system becomes the first FDA-approved device to automatically provide background insulin dosing 24-hours per day for people living with type 1 diabetes.

2020-2021: Guided by our Mission during a pandemic

As COVID-19 swept the globe, we looked to our Mission for guidance. In the first few months, we mobilized to help the heroes on the front lines by increasing ventilator production and publicly sharing design specifications for our portable, compact ventilator. We also created virtual care and telehealth tools for healthcare providers and accelerated the development of remote device management technology, allowing healthcare workers to monitor patients from a distance.
 

2020s: New capabilities in AI, robotic-assisted surgery

In 2021, Medtronic announced the first patient procedure(opens new window) with our new soft-tissue robotic-assisted surgery system. In 2022, the system received additional regulatory approvals in Europe, Japan, and Canada. The groundbreaking technology was designed by surgeons, for surgeons, and it is one of the ways we are expanding our capabilities in the world of data science, machine learning, and artificial intelligence.
 

2024: Our legacy of life-transforming health tech

A lot has changed over the past 75 years, but our Mission to alleviate pain, restore health, and extend life continues to guide us.

  • Open share options
  • 인쇄
  • Email
  • Copy Link
  • Facebook
  • Twitter
  • LinkedIn
  • Close share options
Facebook Youtube LinkedIn Blog

환자와 질환

  • 질환 정보
  • 치료 및 요법

보건의료 전문가

  • 개요 [영문]

우리 회사

  • 회사 정보
  • 사명
  • 리더십
  • 메드트로닉 사업부
  • 역사
  • 위치
  • 뉴스
  • 공지사항
  • 메드트로닉코리아
  • Voice Your Concern
  • 기업지배구조(opens new window)
  • 채용

사회적 책임

  • 사회적 책임
  • 임팩트 리포팅(opens new window)
  • 지역사회
  • 지구
  • 포용성, 다양성, 형평성
  • 의료 형평성
Medtronic logo with tagline Engineering the extraordinary
  • 개인 정보 보호 정책
  • 연락처
L001-03192024 최근 업데이트 November 2024 © 2025 메드트로닉. 02-3404-3600. 서울특별시 강남구 테헤란로 534 글라스타워 17층 ㅣ 대표 유승록 ㅣ 사업자등록번호 120-86-07387